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Myocarditispressing the TNFα gene under the cardiac myosin promoter (TNF1.6) develop
substantially increasedmyocarditis and increased numbers of CD4+Th1 (interferon gamma+) cells when infected
with coxsackievirus B3 (CVB3) during the diestrus and proestrus phases of the estrus cycle compared to females
infected during the estrus andmetestrus phases. Cardiac virus titers were increased in females infected in estrus
compared to females infected during the other phases. T regulatory cells (CD4+CD25+FoxP3+) were increased in
both peripheral blood and inﬂammatory cells in the heart in females infected during estrus. Exogenous
administration of 200 ng/mouse 17-β-estradiol to females protected against CVB3 induced myocarditis and
increased CD4+CD25+FoxP3+ cells. These results demonstrate that hormonal ﬂuctuations occurring in normally
cycling females can determine T regulatory cell response and control virus-induced pathogenesis.
© 2008 Elsevier Inc. All rights reserved.Introduction
Coxsackievirus B3 (CVB3) is a member of the picornavirus family of
small, non-enveloped, positive sense, RNA viruses (Rueckert, 1996), and
are major etiological agents in clinical viral myocarditis (Bowles et al.,
2003; Bowles and Towbin, 2000). A murine model of CVB3 induced
myocarditis has been established which mimicks many of the character-
istics of the clinical disease (Gauntt and Huber, 2003; Gauntt et al., 2000;
Huber et al., 1999a,b; Woodruff, 1980). One aspect of clinical myocarditis
is than men are more likely to develop the disease than women, except
during the third trimester of pregnancy (Woodruff,1980). Similarly, in the
murine model, virgin female mice are generally protected from CVB3
induced myocarditis compared to males and females in the third
trimester of pregnancy (Huber et al., 1982; Huber et al., 1999a,b; Lyden
and Huber, 1984). Sex-associated hormones are predominantly respon-
sible for the gender difference in myocarditis susceptibility with
androgens (testosterone and progesterone) promoting disease and
estrogen inhibiting it (Huber et al., 1982; Lyden and Huber, 1984).
Recently, this laboratory demonstrated that virgin female susceptibility
depends upon the phase of the estrus cycle when infection occurs.
Females infected in diestrus when progesterone levels are naturally
elevated and estradiol levels are reduced results in increasedmyocarditis
compared to females infected during estrus when estradiol levels are
elevated (Schwartz et al., 2004). The effect of infecting mice in different
phasesof the estrus cyclewas consistent buteven females infectedduring
diestrus never achieved the myocarditis severity observed in males or
pregnant females. The increased susceptibility in females infected duringl rights reserved.diestrus correlated to a preferential CD4+Th1 (IFNγ+) cell responsewhile
females infected during estrus showed minimal CD4+ Th1 cells but
increased CD4+Th2 (IL-4+) cells. Sex-associated hormones are well-
known to impact the innate and adaptive immune response. Hormonal
environment can alter dendritic cell maturation and antigen presenta-
tion, cytokine/chemokine expression, and Toll-like receptors (TLR)
expression, all of which can have substantial affects on developing
immunity (Aﬂatoonian et al., 2007; Carreras et al., 2008; Ito et al., 2001,
2002; Kovats and Carreras, 2008). Thus, it is not surprising that the
ﬂuctuating hormonal environment as found during the menstrual cycle
and pregnancy inﬂuences immunity to microbial infections, both in the
genital tract and systemically (Brabin, 2002). Several studies have shown
that hormones modulate T regulatory cell responses (Polanczyk et al.,
2005; Tai et al., 2008) by promoting conversion of CD4+CD25- cells to the
regulatory CD4+CD25+ phenotype. The mechanism appears to be
through estrogen receptors expression on the regulatory cell precursor
and conversion is suppressed by the estrogen receptor. As T regulatory
cells inhibit CD4+Th1 cell responses (Nie et al., 2007), which are essential
to CVB3 induced myocarditis susceptibility (Huber et al., 2002a,b), we
hypothesize that infection of females during the ovarian cycle phases
known to have high estrogen concentrationwould preferentially activate
T regulatory cell responses and suppress Th1 cell dependent diseases.
Results
CVB3 infection increases myocarditis in females infected in diestrus and
proestrus phases of the ovarian cycle
The ﬁrst experiment determined whether estrus cycle affected
heart weight and heart weight:body weight ratios in uninfected
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age) were subjected to vaginal smears and killed immediately to
ensure that the heart and body weights reﬂected the estrus cycle at
the time of euthanasia. Animals were weighed. Hearts were removed
and weighed (Fig. 1). There was no signiﬁcant difference in heart
weight or in heart:body weight ratios in uninfected mice in any of the
phases of the estrus cycle. This demonstrates that the estrus cycle does
not directly alter cardiomyopathy induced by TNFα expression under
the cardiac myosin promoter. Next, females were infected immedi-
ately after the vaginal smear to ensure that infection occurred
speciﬁcally in the estrus phase indicated. Seven days after infection,
mice were killed and hearts were removed and weighed (Fig. 2).
Unlike uninfected TNF1.6 mice, infection during diestrus and
proestrus phases results in signiﬁcantly higher heart weights than
infection during estrus and metestrus. This corresponds to substantial
increases in cardiac inﬂammation in mice infected in diestrus and
proestrus (Figs. 3 and 4). Cardiac virus titers do not correlate to cardiac
inﬂammation since maximum virus occurred in mice infected during
estrus and was signiﬁcantly reduced when mice were infected in
metestrus.
Myocarditis correlates to activated CD4+ and Vγ4+ cells and is inversely
correlated to FoxP3+ T regulatory cells
Previous studies have shown that activated Vγ4+ cells and CD4+
Th1 (IFNγ+) cells are essential to CVB3 induced myocarditis (Huber
et al., 2005; Huber et al., 2002a,b). Therefore, these cell populations
were evaluated in females infected in different phases of the estrus
cycle. Peripheral blood mononuclear cells (PBMC) were isolated from
individual mice and labeled with antibodies to CD4, Vγ4, and either
IFNγ or the early activation marker, CD69, as indications of T cellFig.1. Phase of the estrus cycle has no effect on heart weight or heart:body weight ratios
in uninfected TNF1.6 female mice. Vaginal smears were done and the mice killed
immediately. Animals were weighed. Hearts were perfused with PBS, removed, dried
and weighed. (A) Each point represents the weight of the heart from an individual
animal. Bar indicates mean weight for the group. (B) Mean±SEM heart:body weight
ratio of mice given in (A).
Fig. 2. Female TNF1.6mice infectedwith CVB3 in diestrus andproestrus phases of the estrus
cycle develop more severe cardiomyopathy. Vaginal smears were done and mice infected
with 105 PFU CVB3 i.p. immediately. Mice were killed 7 days after infection and weighed.
Hearts were perfused with PBS, removed, dried and weighed. (A) Each point represents an
individual animal. Bar indicates mean weight for the group. (B) Mean±SEM heart:body
weight ratio of mice given in (A). ⁎⁎Different from mice infected in diestrus at p≤0.01.activation (Fig. 5). Cells were also labeled with antibodies to CD4,
CD25 and FoxP3 to identify T regulatory cells. Animals infected during
diestrus and proestrus had signiﬁcantly increased numbers of both
activated CD4+ (CD4+CD69+ and CD4+IFNγ+) and Vγ4+ (Vγ4+IFNγ+)
cells while these animals had reduced numbers of T regulatory cells
compared to mice infected in estrus. T cells in peripheral blood
potentially may not reﬂect inﬂammatory cell composition in the
inﬂammatory site, in this case, in the heart. Therefore, hearts were
perfused with PBS to remove peripheral blood, minced and enzyma-
tically digested to release inﬂammatory cells. The cells were labeled
with antibodies to CD4, Vγ4, IFNγ, IL-4 and CD4/CD25/FoxP3 (Fig. 6).
As in peripheral blood, increased numbers of CD4+IFNγ+ cells were
observed in the hearts of mice infected in diestrus and proestrus while
increased numbers of CD4+IL-4+ and CD4+CD25+FoxP3+ cells were
found in hearts of mice infected in estrus. Data from both heart and
peripheral blood indicates that activation of T regulatory cells depends
upon the phase of the estrus cycle when females are virally infected.
Role of estradiol in T regulatory cell activation
Previous studies indicate that relatively high levels of estrogen as
seen during pregnancy can activate T regulatory cells (Polanczyk et al.,
2005). Estradiol levels are lower during diestrus compared to estrus
(Schwartz et al., 2004) and this might partially explain the increased
T regulatory cell response observed when mice are infected in estrus. To
demonstrate that estradiol can alter T regulatory cell response during
CVB3 infection, mice were infected and subsequented injected i.p.
Fig. 3. Histology of TNF1.6 mice infected in different phases of the estrus cycle. Vaginal smears were performed and mice were immediately infected i.p. with 105 PFU CVB3. 7 days
later, animals were killed and hearts were removed, formain ﬁxed, parafﬁn embedded, sectioned and stained with hematoxylin and eosin. Photomicrographs are representative of
mice in the group.
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and +3 relative to infection. Mice were killed 7 days after infection
and evaluated for myocardial inﬂammation, cardiac virus titers and
T regulatory cells in PBMC (Fig. 7). Virus titers signiﬁcantly increased in
estradiol treated females infected in diestrus and metestrus. There was a
slight, but not signiﬁcant, increase in virus titers in estradiol treated
females infected in proestrus. Myocarditis was signiﬁcantly reduced in
estradiol treated females in diestrus and proestrus. Estradiol treatment
during early infection signiﬁcantly increased T regulatory cell response in
mice infected during diestrus, proestrus, and metestrus while having no
effect in mice infected in estrus.Fig. 4. Evaluation of cardiac virus titers and myocarditis in female mice infected with CVB3
mice and the animals were immediately infected with 105 PFU CVB3 then killed 7 days lat
inﬂammation using a 0 to 4 grading scale. Results represent mean±SEM of 4 to 11mice/groupDiscussion
This study demonstrates that the phase of the ovarian cycle when
females are infected can have a dramatic impact on anti-virus immunity
and disease susceptibility due to preferential activation of T regulatory
cells. Previous studies have investigated hormonal effects onT regulatory
cell activation in pregnancy (Polanczyk et al., 2005), however, during
pregnancy hormone levels are substantially elevated compared to
levels normally observed in cycling females. The signiﬁcance of the
current work is that more modest hormonal ﬂuctuations still have
major impacts on immune regulation. Serumestradiol levels in diestrusduring different phases of the estrus cycle. Vaginal smears were done on TNF1.6 female
er. Hearts were evaluated for virus titer using the plaque forming assay for myocardial
(heart weights shown in Fig. 2). ⁎Signiﬁcantly different than mice in diestrus at pb0.05.
Fig. 5. Evaluation of immune response of female mice infected with CVB3 during different phases of the estrus cycle. TNF1.6 mice were infected in different phases of the estrus cycle
and killed 7 days later. Peripheral blood mononuclear cells (PBMC) were isolated from individual mice and evaluated by ﬂow cytometry. Results represent mean±SEM of 4 to 11mice/
group. ⁎Signiﬁcantly different from mice infected in diestrus at pb0.05. ⁎⁎Signiﬁcantly different than mice infected in diestrus at p≤0.01.
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Levels in proestrus andmetestrus average approximately 6 and 3 pg/ml,
respectively (Schwartz et al., 2004). For three of the phases (diestrus,
estrus and metestrus) T regulatory response correlates to relative
estradiol levels in that phase being high estradiol level/high T regulatory
cell in estrus but low estradiol/low T regulatory cell in diestrus and
metestrus. An unexpected observation in this study was the low
T regulatory cell response in proestrus when estradiol levels are
elevated. Hormone levels can ﬂuctuate rapidly in mice and females
can move through the ovarian cycle within 1–2 to 10 days. However,
mice underwent vaginal smears and infection almost simultaneously so
that the smears should give an accurate reﬂection of the phase when
infection occurred. One possibility is that while hormone levels changeFig. 6. Characterization of the inﬂammatory cells inﬁltrating the hearts of females
infected during different phases of the estrus cycle. Vaginal smearswere done on female
TNF1.6mice and the animalswere immediately infectedwith 105 PFU CVB3. The animals
were killed 7 days later and the hearts were perfused with PBS, removed, dried, minced
and digestedwith collagenase and pancreatin to retrieve inﬂammatory cells in the heart.
The cells were counted by trypan blue exclusion and labeled with the indicated
antibodies for ﬂow cytometry analysis as described in the Materials and methods.
Number of cells represents the % of cells labeled for particular markers multiplied by the
number of cells recovered from the heart. Results represent the mean±SEM of 4 to 7
mice/group. ⁎Signiﬁcantly different from mice in diestrus at pb0.05.from phase to phase, the expression of the relevant factors controlling
immunity, such as estrogen receptor or cytokine/chemokine expression,
take more time. Animals in proestrus may not have up-regulated these
factors yet despite increasing estradiol levels in the serum. Certainly,
exogenous treatment of females in diestrus, proestrus and metestrus
with estradiol substantially increased T regulatory cell activation during
infection and inhibited myocarditis induction in diestrus and proestrus,
conﬁrming previous studies showing the ability of estrogen to promote
immunoregulatory cells. In thismodel, as expected, therewas an inverse
correlation between the Th1 cell response induced by infection and the
T regulatory cell numbers. The presence of T regulatory cells in mice
infected during estrus would explain the lack of Th1 cell response and
the preferential Th2 activation. Although activation of T regulatory cells
is certainly one important factor determiningmyocarditis susceptibility,
this cannot be the only one. Females infected inmetestrus fail to develop
myocarditis, but also have few detectable T regulatory (CD4+CD25+
FoxP3+) cells. This suggests that other aspects of the metestrus
environment control susceptibility. Previous studies have shown that
exogenous administration of progesterone to virgin females aggravates
CVB3 induced myocarditis to levels usually observed in infected males
(Lyden and Huber, 1984). Progesterone levels during metestrus are low
(b100 pg/ml plasma) compared to elevated levels (~200 pg/ml) during
diestrus, proestrus and estrus (Schwartz et al., 2004). Therefore, this is
the only phase in the ovarian cycle where the hormone associated with
disease susceptibility is low. Low progesterone must prevent activation
of CD4+ Th1 cells without involving T regulatory cells.
Disease susceptibility to a number of infectious agents is affected
by the estrus cycle or sex-associated hormones. In dogs, the onset of
pyometra, an infection of the uterus, occurs during diestrus (Sugiura
et al., 2004). Female mice infected during estrus cycle phases with
high progesterone are better able to clear Trypanosoma cruzi, the
causative agent in Chagas' Disease (Schuster and Schaub, 2001), and
are also less susceptible to pseudorabies infection of the central
nervous system than females infected when progesterone levels are
low (estrus) (Weiss et al., 2001). Infection of the genital tract with
herpes simplex type 2 virus results in strong IgA (Th2 cell dependent)
and low IgG antibody responses during estrus but strong IgG and low
IgA antibody responses during diestrus (Gallichan and Rosenthal,
1996). In Thieler's virus infections, male mice are more susceptible to
Fig. 7. Estradiol treatment reduces myocarditis and increases FoxP3+ T regulatory cell response in female mice. Vaginal smears were done on TNF1.6 mice and the animals were
immediately infected with 105 PFU CVB3. On days +1 and +3 relative to infection, mice were injected i.p. with 200 ng estradiol in PBS or PBS alone. Animals were killed 7 days after
infection. Hearts were evaluated for virus titer and cardiac inﬂammation. PBMC were isolated from individual animals and evaluated for FoxP3+ T cells by ﬂow cytometry. Results
represent mean±SEM of 4 to 6 mice/group. ⁎Signiﬁcantly different frommice in same estrus phase and treated with PBS at pb0.05. ⁎⁎Signiﬁcantly different frommice in same estrus
phase and treated with PBS at p≤0.01.
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dominant Th1 cell response (Kim et al., 2001). Thus, sex-associated
hormones have a potent impact on immunity. The precise nature of the
impact on immune responses can be controversial, however. Generally,
estrogens promote CD4+Th1 immune responses (Delpy et al., 2005;
Karpuzoglu-Sahin et al., 2001; Karpuzoglu et al., 2007), but this is
largely concentration dependent since high estrogen levels associated
with pregnancy also suppress Th1 cell responses (Doria et al., 2006).
Low-level estrogen primes Tcells for T-bet activation, the transcription
factor associated with IFNγ expression and characteristic for Th1 cells
(Karpuzoglu et al., 2007). In contrast, androgens including progester-
one, usually promote Th2 cell responses (Joachim et al., 2003;
Matsuzaki et al., 2005) and apoptosis of Th1 cells (Matsuzaki et al.,
2005). In picornavirus infections, however (coxsackievirus B3 and
Theiler's virus (Fuller et al., 2007; Huber and Pfaefﬂe, 1994; Kim et al.,
2001)), androgens promote Th1 cell responses while estrogens
promote Th2 cell responses. Why androgens preferentially activate
Th1 cell responses in picornavirus infections is not known, but the
answer might involve how sex-associated hormone affect virus
replication (Fuller et al., 2007; Lyden et al., 1987) as increasing or
decreasing virus load (antigen concentrations) could alter the
characteristics of the anti-viral response. Studies clearly show that
antigen dose can determine T cell polarization to either a Th1 (IFNγ+)
or Th2 (IL-4+) phenotype (Hosken et al., 1995) with very low or very
high antigen concentrations producing Th2 polarization. Evaluations
of decay accelerating factor (DAF), one of the known virus receptors for
coxsackieviruses (Bergelson et al., 1995), in young cycling women
show that DAF levels on peripheral blood lymphocytes and infectivity/
virus production by these lymphocytes increases with estrogen levels
in plasma and is highest in the follicular phase (Sartini et al., 2004).
Previously (Huber et al., 2006), it was shown that female BALB/c
mice infected in diestrus and proestrus phases of the ovarian cycle
developed more myocarditis and preferential CD4+Th1 cell responses
while females infected in estrus and metestrus phases developed
preferential CD4+Th2 cell responses and less cardiac inﬂammation.
The current paper provides additional information by showing thatT regulatory cells are induced when females are infected in estrus and
that this inhibits myocarditis induction. It is important that the basic
pattern of myocarditis susceptibility is identical in BALB/c and TNF1.6
animals with suppressed disease in females infected in the estrus
phase. This result indicates that hormonal impact on coxsackieviral
viral disease is not mouse strain dependent. A valid question is why
the current report uses TNF1.6 transgenic mice when the earlier study
used BALB/c animals. Although infecting BALB/c females in different
phases of the estrus phase produced consistent, reproducible and
signiﬁcant changes in cardiac inﬂammation, the differences were
nonetheless modest and required actually counting individual small
inﬂammatory loci each consisting usually of only 10–20 inﬂammatory
cells. In contrast, differences in myocarditis severity in the transgenic
animals expressing the TNFα gene under the cardiac myosin promoter
are dramatic and allow evaluation by image analysis and by heart/
body weights. The presence of transgenically expressed TNFα does
not alter the pattern of myocarditis susceptibility but dramatically
accentuates the differences in disease severity and the protective
capacity of infecting females in estrus. TNF1.6mice speciﬁcally express
high TNFα concentrations in the heart but not in any other tissues or
in the blood (Huber et al., 2006; Kubota et al., 1997). TNFα is essential
to myocarditis susceptibility (Lane et al., 1992, 1993) and is required
for activation of T cells expressing the γδ T cell receptor (Huber and
Sartini, 2005) which are important mediators of viral pathogenicity
(Huber et al., 2002a,b). Thus, use of these transgenic mice ampliﬁes
the effects of coxsackievirus B3 infection in females making differ-
ences in myocarditis severity between groups much more dramatic
than would be observed in wild-type mice where inherent levels of
TNFα in the heart are negligible. It is important to note, however, that
the presence of TNFα in the heart is not contributing to differences
observed in infected females during the estrus cycle since neither
cardiac inﬂammation or heart weight change in uninfected TNF1.6
mice with estrus cycle phase (Fig. 1).
Whether hormonal ﬂuctuations impact clinical myocarditis suscept-
ibility is unclear. Men are more likely to develop clinical myocarditis
than women. Susceptibility in women may increase during the
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of coxsackievirus B3 induced myocarditis where male mice are more
susceptible than females but females become highly susceptible to viral
myocarditis during the third trimester of pregnancy and post-partum
(Huber et al., 1982; Lyden and Huber, 1984). It is conceivable therefore
that estrogen treatments might prove beneﬁcial in clinical myocarditis,
especially in clinical disease caused by inﬂammatory mediators. Other
studies also ﬁnd that estrogen promotes T regulatory cell responses
(Polanczyk et al., 2005; Tai et al., 2008) meaning that T regulatory cell
responses to estrogen treatmentmightbe a consistentphenomenonand




Female TNF1.6 transgenic mice were used at 6–8 weeks of age. The
TNF1.6 mice have cardiac-speciﬁc TNFα over-expression and were
made by microinjecting the TNFα construct into pronuclei of one cell
FVB mouse embryos and implanting the embryos into pseudopreg-
nant mice as described byKubato et al (1997). Transgenic mice are
homozygous for the FVB background. Breeding pairs were kindly
supplied by Dr. A.M. Feldman (Department of Medicine, Center for
Translational Medicine, Thomas Jefferson University, Philadelphia, PA)
and have been maintained by heterozygous (TNF1.6+/-) by wild-type
(+/+) breeding.
Vaginal smears
Vaginal epithelial cells were obtained frommice and smeared onto
pre-cleaned Superfrost Plus slides. Smears were done between 8 and
11 am each day. Slides were stained with Hematoxylin, modiﬁed
Papanicolaou stain OG6, and Papanicolaou modiﬁed EA stain. Slides
were then coverslipped and evaluated for presence of white blood
cells and presence and morphology of epithelial cells to determine
estrus cycle stage as previously published (Cohen et al., 2002). Mice
were infected with virus within 1 min of the time the vaginal smears
were obtained.
Virus infection and titration
The H3 variant of CVB3 was used (Knowlton et al., 1996). Adult
mice were infected by intraperitoneal injection with 105 PFU virus in
phosphate buffered saline (PBS). Animals were killed 7 days after
infection. Hearts were removed, and titered using the plaque forming
assay (Knowlton et al., 1996).
Hormone treatment
17-β-estradiol (Sigma Chemical Co., St. Louis, MO) was initially
diluted in 100% ethanol then diluted to 400 ng/ml in PBS. Mice were
injected i.p. with either 200 ng/mouse estradiol or PBS on days +1 and
+3 relative to infection.
Flow cytometry
Details for intracellular cytokine staining have been published
previously (Huber et al., 2001). Lymphoid cells were either isolated
from peripheral blood or from the heart. Peripheral blood was taken
from euthanized mice by cardiac puncture into EDTA-PBS. Lymphoid
cells were isolated by centrifugation on Histopaque (Sigma). Inﬂam-
matory cells in the heart were isolated by perfusing individual hearts
with PBS, mincing ﬁnely, digesting the hearts with 0.4% collagenase II
(Sigma Chemical Co, St. Louis MO) and 0.25% pancreatin (Sigma), then
centrifuging the cell suspension on Histopaque (Sigma) (Huber et al.,2006). For intracellular cytokine staining, 106 cells were cultured for
4 h in RPMI 1640 medium containing 5% fetal bovine serum, 10 μg/ml
Brefeldin A (BFA), 50 ng/ml phorbol myristate acetate (PMA), and
500 ng/ml ionomycin (Sigma). After culture, the cells were washed in
PBS-1% bovine serum albumin (BSA; Sigma) containing BFA, and
labeled with PerCP-Cy5.5-anti-CD4 (clone GK1.5, BD Sciences, Fair
Lawn, NJ), andAPC-Cy7-anti-Vγ4 (cloneUC3) for 30min,washed, then
ﬁxed in 2% paraformaldehyde for 10 min. The cells were resuspended
in PBS-BSA containing 0.5% saponin, Fc Block and 1:100 dilutions of PE-
anti-IFNγ (cloneXMG1.2), Alexa 647-anti-IL-4 (clone 11B11), or PE and
Alexa 647- rat IgG1 (clone R3-34) and incubated for 30min on ice. The
cells were washed once in PBS-BSA-saponin and once in PBS-BSA, the
resuspended in 2% paraformaldehyde. FoxP3 labeling was done using
the eBioscience kit according to manufacturer's directions. Cells were
labeled with Alexa647 anti-CD4 and PerCP-Cy5.5 anti-CD25 (clone
PC61) in PBS-1%BSA containing FcBlock, washed, ﬁxed and permea-
bilized, then incubated with PE-anti-FoxP3 and FcBlock overnight at
4 °C. Cellswerewashed and resuspended in PBS-2%paraformaldehyde.
Additional cells were incubated with Alexa 647-anti-CD4 and PerCP-
Cy5.5-anti-CD69 (clone H1.2F3), washed and resuspended in PBS-2%
paraformaldehyde. Cells were analyzed using a Coulter Epics Elite ﬂow
cytometer with a single excitation wavelength (488 nm) and band
ﬁlters for FITC (525 nm), PerCP-Cy5.5 (695/40 nm), and PE (575 nm).
The excitationwavelength for Alexa 647 is 643 nm and a band ﬁlter of
660/20 nm. The excitation wavelength for APC-Cy7 was 595 nm and a
band ﬁlter of 650 nm. The cell population was classiﬁed for cell size
(forward scatter) and complexity (side scatter). At least 10,000 cells
were evaluated. Positive staining was determined relative to isotype
controls.
Histology
The apical half of the heart was ﬁxed in 10% buffered formalin,
sectioned, and stained with hematoxylin and eosin. Sections were
scored blindly for inﬂammation using a 0 to 4 scalewhere 0 represents
no inﬂammation and 4 represents extensive conﬂuent inﬂammation.
Statistics
Statistical analysis was done by Wilcoxon Ranked Score.
Acknowledgments
This work was supported by National Institutes of Health grants
HL80594, HL86549 and AI45666. The authors also wish to thank
Colette Charland for her help with ﬂow cytometry and Kevin Kolinich
for his help in preparing the manuscript.
References
Aﬂatoonian, R., Tuckerman, E., Elliott, S.L., Bruce, C., Aﬂatoonian, A., Li, T.C., Fazeli, A.,
2007. Menstrual cycle-dependent changes of toll-like receptors in endometrium.
Hum. Reprod. 22 (2), 586–593.
Bergelson, J.M., Mohanty, J.G., Crowell, R.L., St John, N.F., Lublin, D.M., Finberg, R.W.,
1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating
factor (CD55). J. Virol. 69 (3), 1903–1906.
Bowles, N.E., Ni, J., Kearney, D.L., Pauschinger, M., Schultheiss, H.P., McCarthy, R., Hare, J.,
Bricker, J.T., Bowles, K.R., Towbin, J.A., 2003. Detection of viruses in myocardial
tissues by polymerase chain reaction evidence of adenovirus as a common cause of
myocarditis in children and adults. J. Am. Coll. Cardiol. 42 (3), 466–472.
Bowles, N.E., Towbin, J.A., 2000. Molecular aspects of myocarditis. Curr. Infect. Dis. Rep.
2 (4), 308–314.
Brabin, L., 2002. Interactions of the female hormonal environment, susceptibility to
viral infections, and disease progression. AIDS Patient Care STDS 16 (5), 211–221.
Carreras, E., Turner, S., Paharkova-Vatchkova, V., Mao, A., Dascher, C., Kovats, S., 2008.
Estradiol acts directly on bone marrow myeloid progenitors to differentially
regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. J. Immunol.
180 (2), 727–738.
Cohen, P.E., Zhu, L., Nishimura, K., Pollard, J.W., 2002. Colony-stimulating factor 1
regulation of neuroendocrine pathways that control gonadal function in mice.
Endocrinology 143 (4), 1413–1422.
298 S.A. Huber / Virology 378 (2008) 292–298Delpy, L., Douin-Echinard, V., Garidou, L., Bruand, C., Saoudi, A., Guery, J.C., 2005.
Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis
by promoting type 1-polarized immune responses. J. Immunol. 175 (8), 5050–5057.
Doria, A., Iaccarino, L., Arienti, S., Ghirardello, A., Zampieri, S., Rampudda, M.E., Cutolo,
M., Tincani, A., Todesco, S., 2006. Th2 immune deviation induced by pregnancy: the
two faces of autoimmune rheumatic diseases. Reprod. Toxicol. 22 (2), 234–241.
Fuller, A., Yahikozawa, H., So, E.Y., Dal Canto, M., Koh, C.S., Welsh, C.J., Kim, B.S., 2007.
Castration of male C57L/J mice increases susceptibility and estrogen treatment
restores resistance to Theiler's virus-induced demyelinating disease. J. Neurosci.
Res. 85 (4), 871–881.
Gallichan, W.S., Rosenthal, K.L., 1996. Effects of the estrous cycle on local humoral
immune responses and protection of intranasally immunized female mice against
herpes simplex virus type 2 infection in the genital tract. Virology 224 (2), 487–497.
Gauntt, C., Huber, S., 2003. Coxsackievirus experimental heart diseases. Front. Biosci. 8,
E23–35.
Gauntt, C., Sakkinen, P., Rose, N., Huber, S., 2000. Picornaviruses: immunopathology and
autoimmunity. In: Cunningham, M., Fujinami, R. (Eds.), Effects of Microbes on the
Immune System. Lippincott-Raven Publishers, Philadelphia, pp. 313–329.
Hosken, N.A., Shibuya, K., Heath, A.W., Murphy, K.M., O'Garra, A., 1995. The effect of
antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-
alpha beta-transgenic model. J. Exp. Med. 182 (5), 1579–1584.
Huber, S., Pfaefﬂe, B., 1994. Differential Th1 and Th2 cell responses in male and female
BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68, 5126–5132.
Huber, S.A., Sartini, D., 2005. Roles of tumor necrosis factor alpha (TNF-alpha) and the
p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.
J. Virol. 79 (5), 2659–2665.
Huber, S., Job, L., Auld, K., 1982. Inﬂuence of sex hormones on coxsackie B3 virus
infection in Balb/c mice. Cell. Immunol. 67 (173–189), 173–179.
Huber, S., Kupperman, J., Newell, M., 1999a. Hormonal regulation of CD4+ T-cell
responses in coxsackievirus B3-inducedmyocarditis inmice. J. Virol. 73, 4689–4695.
Huber, S.A., Gauntt, C.J., Sakkinen, P., 1999b. Enteroviruses and myocarditis: Viral
pathogenesis through replication, cytokine induction and immunopathogenicity.
Advances in Virus Res. 51, 35–80.
Huber, S., Graveline, D., Born, W., O'Brien, R., 2001. Cytokine production by Vgamma+
T cell subsets is an important factor determining CD4+ Th cell phenotype and
susceptibility ofBALB/cmice to coxsackievirus B3-inducedmyocarditis. J. Virol. 75 (13),
5860–5868.
Huber, S., Shi, C., Budd, R.C., 2002a. Gammadelta T cells promote a Th1 response during
coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J. Virol. 76 (13),
6487–6494.
Huber, S.A., Sartini, D., Exley,M., 2002b. Vgamma4(+) Tcells promote autoimmune CD8(+)
cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice:
role for CD4(+) Th1 cells. J. Virol. 76 (21), 10785–10790.
Huber, S.A., Born, W., O'Brien, R., 2005. Dual functions of murine gammadelta cells in
inﬂammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of
Vgamma1+ and Vgamma4+ cells. Microbes. Infect. 7 (3), 537–543.
Huber, S.A., Feldman, A.M., Sartini, D., 2006. Coxsackievirus B3 induces T regulatory
cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Circ. Res. 99 (10), 1109–1116.
Ito, A., Bebo Jr., B.F., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., Offner, H.,
2001. Estrogen treatment down-regulates TNF-alpha production and reduces the
severity of experimental autoimmune encephalomyelitis in cytokine knockout
mice. J. Immunol. 167 (1), 542–552.
Ito, A., Buenafe, A.C., Matejuk, A., Zamora, A., Silverman, M., Dwyer, J., Vandenbark, A.A.,
Offner, H., 2002. Estrogen inhibits systemic T cell expression of TNF-alpha and
recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice
developing experimental encephalomyelitis. Clin. Immunol. 102 (3), 275–282.
Joachim, R., Zenclussen, A.C., Polgar, B., Douglas, A.J., Fest, S., Knackstedt, M., Klapp, B.F.,
Arck, P.C., 2003. The progesterone derivative dydrogesterone abrogates murine
stress-triggered abortion by inducing a Th2 biased local immune response. Steroids
68 (10–13), 931–940.Karpuzoglu-Sahin, E., Hissong, B.D., Ansar Ahmed, S., 2001. Interferon-gamma levels are
upregulated by 17-beta-estradiol and diethylstilbestrol. J. Reprod. Immunol. 52 (1–2),
113–127.
Karpuzoglu, E., Phillips, R.A., Gogal Jr., R.M., Ansar Ahmed, S., 2007. IFN-gamma-
inducing transcription factor, T-bet is upregulated by estrogen in murine
splenocytes: role of IL-27 but not IL-12. Mol. Immunol. 44 (7), 1808–1814.
Kim, B.S., Lyman, M.A., Kang, B.S., Kang, H.K., Lee, H.G., Mohindru, M., Palma, J.P., 2001.
Pathogenesis of virus-induced immune-mediated demyelination. Immunol. Res. 24 (2),
121–130.
Knowlton, K.U., Jeon, E.S., Berkley, N., Wessely, R., Huber, S., 1996. A mutation in the puff
region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the
Woodruff variant of coxsackievirus B3. J. Virol. 70 (11), 7811–7818.
Kovats, S., Carreras, E., 2008. Regulation of dendritic cell differentiation and function by
estrogen receptor ligands. Cell Immunol.
Kubota, T., McTiernan, C., Frye, C., Slawson, S., Lemster, B., Koretsky, A., Demetris, A.,
Feldman, A., 1997. Dilated cardiomyopathy in transgenic mice with cardiac-speciﬁc
overexpression of tumor necrosis factor-alpha. Circ. Res. 81, 627–635.
Lane, J., Neumann, D., Lafond-Walker, A., Herkowitz, A., Rose, N., 1992. Interleukin 1 or
tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant
B10.A mice. J. Exp. Med. 175, 1123–1129.
Lane, J., Neumann, D., Lanfond-Walker, A., Herskowitz, A., Rose, N., 1993. Role of IL-1 and
tumornecrosis factor in coxsackievirus-induced autoimmunemyocarditis. J. Immunol.
151, 1682–1690.
Lyden, D., Huber, S., 1984. Aggrevation of coxsackievirus group B type 3-induced
myocarditis and increase in cellular immunity to myocyte antigens in pregnant
BALB/c mice and animals treated with progesterone. Cell. Immunol. 87, 462–472.
Lyden, D., Olszewski, J., Feran, M., Job, L., Huber, S., 1987. Coxsackievirus B3-induced
myocarditis. Effects of sex steroids on viremia and infectivity of cardiocytes. Am. J.
Pathol. 126, 432–438.
Matsuzaki, J., Tsuji, T., Imazeki, I., Ikeda, H., Nishimura, T., 2005. Immunosteroid as a
regulator for Th1/Th2 balance: its possible role in autoimmune diseases.
Autoimmunity 38 (5), 369–375.
Nie, C.Q., Bernard, N.J., Schoﬁeld, L., Hansen, D.S., 2007. CD4+ CD25+ regulatory T cells
suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-
speciﬁc TH1 responses involved incerebralmalariapathogenesis. Infect. Immun. 75 (5),
2275–2282.
Polanczyk, M.J., Hopke, C., Huan, J., Vandenbark, A.A., Offner, H., 2005. Enhanced
FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice.
J. Neuroimmunol. 170 (1–2), 85–92.
Rueckert, R., 1996. Picronaviruses, In: Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.),
Fundamental Virology, 3rd Ed. Lippincott-Raven, Philadelphia, PA.
Sartini, D., Moussawi, M., Sallam, R., Bernstein, I., Huber, S., 2004. Correlation between
serum estradiol in the follicular phase of the ovarian cycle and decay acceleration
factor (DAF) expression on red blood cells and coxsackiervirus B-3 induced
hemagglutination inyoung cyclingwomen. Am. J. Reprod. Immunol. 51 (2),180–187.
Schuster, J.P., Schaub, G.A., 2001. Trypanosoma cruzi: the development of estrus cycle
and parasitemia in female mice maintained with or without male pheromones.
Parasitol. Res. 87 (12), 985–993.
Schwartz, J., Sartini, D., Huber, S., 2004. Myocarditis susceptibility in female mice
depends upon ovarian cycle phase at infection. Virology 330 (1), 16–23.
Sugiura, K., Nishikawa, M., Ishiguro, K., Tajima, T., Inaba, M., Torii, R., Hatoya, S.,
Wijewardana, V., Kumagai, D., Tamada, H., Sawada, T., Ikehara, S., Inaba, T., 2004.
Effect of ovarian hormones on periodical changes in immune resistance associated
with estrous cycle in the beagle bitch. Immunobiology 209 (8), 619–627.
Tai, P., Wang, J., Jin, H., Song, X., Yan, J., Kang, Y., Zhao, L., An, X., Du, X., Chen, X., Wang, S.,
Xia, G., Wang, B., 2008. Induction of regulatory T cells by physiological level
estrogen. J. Cell. Physiol. 214 (2), 456–464.
Weiss, M.L., Dobbs, M.E., MohanKumar, P.S., Chowdhury, S.I., Sawrey, K., Guevara-
Guzman, R., Huang, J., 2001. The estrous cycle affects pseudorabies virus (PRV)
infection of the CNS. Brain Res. 893 (1–2), 215–226.
Woodruff, J., 1980. Viral myocarditis. Am. J. Pathol. 101, 425–483.
